{"id":25870,"date":"2026-01-27T11:16:29","date_gmt":"2026-01-27T09:16:29","guid":{"rendered":"https:\/\/makingpharmaindustry.it\/?p=25870"},"modified":"2026-01-27T11:16:29","modified_gmt":"2026-01-27T09:16:29","slug":"europes-new-pharmaceutical-legislation-takes-shape","status":"publish","type":"post","link":"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/","title":{"rendered":"Europe\u2019s new pharmaceutical legislation takes shape"},"content":{"rendered":"<p data-start=\"939\" data-end=\"1343\">The revision of <strong>European pharmaceutical legislation<\/strong> is far more than a routine regulatory update. It represents the most extensive overhaul of the EU pharmaceutical framework in over twenty years. The European Commission\u2019s ambition is clear: to create a system capable of balancing innovation, equitable access to medicines and industrial sustainability in an increasingly competitive global environment.<\/p>\n<p data-start=\"1345\" data-end=\"1706\">The proposal stems from the recognition that the current regulatory framework no longer fully addresses today\u2019s challenges. Persistent inequalities in access to medicines among Member States, repeated supply shortages and Europe\u2019s declining attractiveness as a hub for pharmaceutical research and development have all highlighted the need for structural reform.<\/p>\n<h2 data-start=\"1713\" data-end=\"1762\">Incentives, access and security of supply<\/h2>\n<p data-start=\"1764\" data-end=\"2052\">One of the central pillars of the reform concerns incentives for innovation. The proposed revision of regulatory protection mechanisms seeks to strike a new balance between safeguarding R&amp;D investments and ensuring faster and more consistent access to medicines across the European Union.<\/p>\n<p data-start=\"2054\" data-end=\"2485\">At the same time, <strong>the reform places strong emphasis on the availability of essential medicines<\/strong>. Recent shortages have exposed the fragility of global supply chains and the urgent need for more effective regulatory and industrial tools to prevent and manage disruptions. In this context, the new framework introduces measures aimed at strengthening European coordination and enhancing the resilience of pharmaceutical supply chains.<\/p>\n<h2 data-start=\"2492\" data-end=\"2539\">Opportunities and unresolved challenges<\/h2>\n<p data-start=\"2541\" data-end=\"2880\">Despite the progress achieved, the legislative process is far from complete. Several critical issues remain under discussion, including the potential impact of the reform on investment decisions, Europe\u2019s long-term capacity to support innovation and the risk of weakening the global competitiveness of the European pharmaceutical industry.<\/p>\n<p data-start=\"2882\" data-end=\"3237\">The ongoing dialogue between European institutions, Member States and industry stakeholders will be decisive in shaping the final outcome. For companies operating along the pharmaceutical value chain, understanding the direction of the reform today is essential to prepare for regulatory and market scenarios that will shape the sector in the years ahead.<\/p>\n<p data-start=\"3239\" data-end=\"3501\">\ud83d\udc49 <strong data-start=\"3242\" data-end=\"3442\">A detailed and up-to-date analysis of the progress of the new European pharmaceutical legislation is available in the full article published on the website of <span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">EIPG<\/span><\/span><\/strong>, which we recommend for an in-depth technical perspective.<\/p>\n<p style=\"text-align: center;\" data-start=\"3239\" data-end=\"3501\"><a href=\"https:\/\/www.eipg.eu\/many-advancements-in-the-setting-up-of-the-new-pharmaceutical-legislation\/\" target=\"_blank\" rel=\"noopener\"><span class=\"td_btn td_btn_md td_round_btn\">Discover the EIPG article<\/span><\/a><\/p>\n<div id=\"tw-container\" class=\"nev7se\" data-cp=\"1\" data-nnttsvi=\"1\" data-sletp=\"false\" data-sm=\"1\" data-ssbp=\"true\" data-sugg-time=\"500\" data-sugg-url=\"https:\/\/clients1.google.com\/complete\/search\" data-uilc=\"it\" data-vil=\",af,af-ZA,am,am-ET,ar-EG,ar-AE,ar-KW,ar-QA,ar,ar-IL,ar-JO,ar-LB,ar-PS,az,az-AZ,bg,bg-BG,bn,bn-BD,bn-IN,ca,ca-es,cs,cs-CZ,de,de-DE,de-CH,de-AT,de-LI,en,en-US,en-CA,en-AU,en-NZ,en-GB,en-IN,en-KE,en-TZ,en-NG,en-GH,en-PH,en-ZA,es,es-ES,es-AR,es-UY,es-419,es-BO,es-CL,es-CR,es-CO,es-DO,es-EC,es-GT,es-HN,es-NI,es-PA,es-PE,es-PR,es-PY,es-SV,es-VE,es-MX,es-US,eu,eu-ES,fi,fi-FI,fr,fr-FR,fr-CH,fr-BE,gl,gl-ES,gu,gu-IN,he,he-IL,iw,iw-IL,hu,hu-HU,hy,hy-AM,id,id-ID,is,is-IS,it,it-IT,it-CH,ja,ja-JP,jv,jv-ID,ka,ka-GE,km,km-KH,kn,kn-IN,ko,ko-KR,la,lo,lo-LA,lv,lv-LV,ml,ml-IN,mr,mr-IN,ms,ms-MY,nl,nl-NL,nb,nb-NO,ne,ne-NP,pl,pl-PL,pt,pt-BR,pt-PT,ro,ro-RO,ru,ru-RU,si-LK,sk,sk-SK,sr,sr-RS,su,su-ID,sv,sv-SE,sw,sw-TZ,sw-KE,ta,ta-IN,ta-SG,ta-LK,ta-MY,te,te-IN,tr,tr-TR,ur,ur-PK,ur-IN,yue,yue-HK,yue-Hant-HK,zh-HK,zh,zh-CN,zh-cmn,zh-cmn-CN,zh-Hans,zh-Hans-CN,zh-cmn-Hans,zh-cmn-Hans-CN,cmn-CN,cmn-Hans,cmn-Hans-CN,zh-TW,zh-Hant-TW,cmn-TW,cmn-Hant-TW,zh-cmn-TW,zh-cmn-Hant-TW,zu,zu-ZA,hi,hi-IN,tl,tl-PH,pa,pa-IN\">\n<div id=\"tw-ob\" class=\"tw-src-ltr\">\n<div class=\"oSioSc\">\n<div id=\"tw-target\">\n<div id=\"kAz1tf\" class=\"g9WsWb PZPZlf\" data-attrid=\"tw-targetArea\" data-entityname=\"Google Translate\">\n<div class=\"iYB33c\">\n<div id=\"tw-tmenu\" class=\"tw-menu\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"tw-images\"><\/div>\n<div class=\"dURPtb\"><\/div>\n<div>\n<div><\/div>\n<\/div>\n<\/div>\n<div class=\"KFFQ0c xKf9F\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>The reform of European pharmaceutical legislation is entering its most concrete phase. Innovation incentives, access to medicines and security of supply are at the core of a regulatory overhaul set to reshape the EU pharmaceutical ecosystem.<\/p>\n","protected":false},"author":6,"featured_media":25877,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[818],"tags":[],"class_list":{"0":"post-25870","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-regulatory"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Europe\u2019s new pharmaceutical legislation takes shape - MakingPharmaIndustry<\/title>\n<meta name=\"description\" content=\"Europe\u2019s pharmaceutical legislation is being reshaped: innovation incentives, access to medicines and supply security\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Europe\u2019s new pharmaceutical legislation takes shape - MakingPharmaIndustry\" \/>\n<meta property=\"og:description\" content=\"Europe\u2019s pharmaceutical legislation is being reshaped: innovation incentives, access to medicines and supply security\" \/>\n<meta property=\"og:url\" content=\"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/\" \/>\n<meta property=\"og:site_name\" content=\"MakingPharmaIndustry\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-27T09:16:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2026\/01\/ChatGPT-Image-27-gen-2026-10_15_14.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Redazione\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Redazione\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/\"},\"author\":{\"name\":\"Redazione\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/7b0796bcde491afd1546eace86de0808\"},\"headline\":\"Europe\u2019s new pharmaceutical legislation takes shape\",\"datePublished\":\"2026-01-27T09:16:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/\"},\"wordCount\":368,\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2026\/01\/ChatGPT-Image-27-gen-2026-10_15_14.png\",\"articleSection\":[\"REGULATORY\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/\",\"name\":\"Europe\u2019s new pharmaceutical legislation takes shape - MakingPharmaIndustry\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2026\/01\/ChatGPT-Image-27-gen-2026-10_15_14.png\",\"datePublished\":\"2026-01-27T09:16:29+00:00\",\"author\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/7b0796bcde491afd1546eace86de0808\"},\"description\":\"Europe\u2019s pharmaceutical legislation is being reshaped: innovation incentives, access to medicines and supply security\",\"breadcrumb\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/#primaryimage\",\"url\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2026\/01\/ChatGPT-Image-27-gen-2026-10_15_14.png\",\"contentUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2026\/01\/ChatGPT-Image-27-gen-2026-10_15_14.png\",\"width\":1536,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/makingpharmaindustry.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Europe\u2019s new pharmaceutical legislation takes shape\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/\",\"name\":\"MakingPharmaIndustry\",\"description\":\"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/7b0796bcde491afd1546eace86de0808\",\"name\":\"Redazione\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/385a31cd755c5e17c9892452fa035dad200ba77019438da992e6cfeb2d35483e?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/385a31cd755c5e17c9892452fa035dad200ba77019438da992e6cfeb2d35483e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/385a31cd755c5e17c9892452fa035dad200ba77019438da992e6cfeb2d35483e?s=96&d=mm&r=g\",\"caption\":\"Redazione\"},\"url\":\"https:\/\/makingpharmaindustry.it\/en\/author\/maura-bernini\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Europe\u2019s new pharmaceutical legislation takes shape - MakingPharmaIndustry","description":"Europe\u2019s pharmaceutical legislation is being reshaped: innovation incentives, access to medicines and supply security","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/","og_locale":"en_US","og_type":"article","og_title":"Europe\u2019s new pharmaceutical legislation takes shape - MakingPharmaIndustry","og_description":"Europe\u2019s pharmaceutical legislation is being reshaped: innovation incentives, access to medicines and supply security","og_url":"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/","og_site_name":"MakingPharmaIndustry","article_published_time":"2026-01-27T09:16:29+00:00","og_image":[{"width":1536,"height":1024,"url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2026\/01\/ChatGPT-Image-27-gen-2026-10_15_14.png","type":"image\/png"}],"author":"Redazione","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Redazione","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/#article","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/"},"author":{"name":"Redazione","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/7b0796bcde491afd1546eace86de0808"},"headline":"Europe\u2019s new pharmaceutical legislation takes shape","datePublished":"2026-01-27T09:16:29+00:00","mainEntityOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/"},"wordCount":368,"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2026\/01\/ChatGPT-Image-27-gen-2026-10_15_14.png","articleSection":["REGULATORY"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/","url":"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/","name":"Europe\u2019s new pharmaceutical legislation takes shape - MakingPharmaIndustry","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/#primaryimage"},"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2026\/01\/ChatGPT-Image-27-gen-2026-10_15_14.png","datePublished":"2026-01-27T09:16:29+00:00","author":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/7b0796bcde491afd1546eace86de0808"},"description":"Europe\u2019s pharmaceutical legislation is being reshaped: innovation incentives, access to medicines and supply security","breadcrumb":{"@id":"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/#primaryimage","url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2026\/01\/ChatGPT-Image-27-gen-2026-10_15_14.png","contentUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2026\/01\/ChatGPT-Image-27-gen-2026-10_15_14.png","width":1536,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/makingpharmaindustry.it\/en\/regulatory\/europes-new-pharmaceutical-legislation-takes-shape\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/makingpharmaindustry.it\/en\/"},{"@type":"ListItem","position":2,"name":"Europe\u2019s new pharmaceutical legislation takes shape"}]},{"@type":"WebSite","@id":"https:\/\/makingpharmaindustry.it\/en\/#website","url":"https:\/\/makingpharmaindustry.it\/en\/","name":"MakingPharmaIndustry","description":"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/7b0796bcde491afd1546eace86de0808","name":"Redazione","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/385a31cd755c5e17c9892452fa035dad200ba77019438da992e6cfeb2d35483e?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/385a31cd755c5e17c9892452fa035dad200ba77019438da992e6cfeb2d35483e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/385a31cd755c5e17c9892452fa035dad200ba77019438da992e6cfeb2d35483e?s=96&d=mm&r=g","caption":"Redazione"},"url":"https:\/\/makingpharmaindustry.it\/en\/author\/maura-bernini\/"}]}},"_links":{"self":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/25870","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/comments?post=25870"}],"version-history":[{"count":2,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/25870\/revisions"}],"predecessor-version":[{"id":25876,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/25870\/revisions\/25876"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media\/25877"}],"wp:attachment":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media?parent=25870"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/categories?post=25870"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/tags?post=25870"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}